Quest Laboratories IPO GMP

Quest Laboratories – Are you looking for Quest Laboratories IPO GMP / Grey Market Premium and Kostak rate? You are at the right place, here you will get the latest Quest Laboratories IPO GMP live.

The public issue of Quest Laboratories will open on May 15, 2024 and remain open until May 17, 2024 for bidding. It has set the price band at approximately ₹93 to ₹97 per equity share and expects to raise ₹43.16 crore.

Ahead of Quest Laboratories opening date, grey market indicators are pointing to positive developments.

Quest Laboratories IPO GMP

Quest Laboratories Grey Market Premium (GMP) is currently at No GMP data found, indicating the demand for the company's shares in the unofficial market.

Quest Laboratories IPO price band

The price band for Quest Laboratories initial public offering (IPO) has been set at ₹93 to ₹97 per equity share, offering potential investors a range within which they can place their bids.

Quest Laboratories IPO date

Starting from May 15, 2024, the IPO will be open for bidders to participate, and it will remain open until May 17, 2024, providing a limited window for interested parties to take part in the offering.

Quest Laboratories IPO size

With an ambitious goal of raising ₹43.16 Crores, Quest Laboratories is poised to make a significant impact in the financial markets through its IPO.

Quest Laboratories IPO lot size

Investors can apply for the IPO in lots, with each lot comprising 1200 shares, allowing them to tailor their investment based on their financial capacity and strategic objectives.

Quest Laboratories IPO application limit

The application limit for the IPO is set at a minimum of 1 lot for bidders, while retail investors have the opportunity to apply for up to 1 lots, offering flexibility in participation.

Quest Laboratories allotment date

The tentative schedule for the allotment of Quest Laboratories IPO shares is May 21, 2024, providing a timeline for successful bidders to receive their allocated shares.

Quest Laboratories IPO listing

Quest Laboratories aims to list its shares on May 23, 2024, subject to market conditions, with plans to list on both the BSE and NSE, signaling a significant milestone for the company.

Quest Laboratories IPO registrar

Bigshare Services Pvt Ltd has been entrusted with the crucial role of serving as the registrar for Quest Laboratories, ensuring a smooth and efficient process for all stakeholders involved.

Investors and market analysts are closely monitoring the developments surrounding Quest Laboratories IPO, as it presents an opportunity to gauge the market's response to the company's offering. The subscription data and final oversubscription figures will provide valuable insights into the demand for AIK Pipes And Polymers's shares and the overall investor sentiment.

Quest Laboratories IPO is generating considerable interest due to the company's strong presence in the engineering and design services sector, as well as its diverse client base spanning various industries. Additionally, the IPO's performance will be indicative of investor confidence in the broader economic outlook and the attractiveness of the Indian capital markets.

As the IPO progresses through its various stages, prospective investors will closely analyze factors such as the company's financial performance, growth prospects, and competitive positioning to make informed decisions about participating in the offering. This heightened interest is expected to contribute to robust trading activity following the listing of Quest Laboratories shares.

The successful execution of Quest Laboratories IPO is anticipated to further bolster the company's financial position and provide funds for strategic initiatives, expansion plans, and potential acquisitions. Moreover, it will offer an opportunity for retail investors, institutional investors, and other market participants to gain exposure to a prominent player in the engineering and design services sector.

Overall, Quest Laboratories IPO is poised to make a significant impact on the Indian markets, and its outcome will be closely observed as a barometer of investor confidence and market dynamics.